Mystic Asset Management, Inc. Bausch Health Companies Inc. Transaction History

Mystic Asset Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 21, 2023	SELL	$6.28 - $9.85 $6,280 - $9,850	-1,000 Reduced 1.77%	55,500 $449,000
Q4 2022 Feb 03, 2023	SELL	$6.09 - $7.93 $337,995 - $440,115	-55,500 Reduced 49.55%	56,500 $354,000
Q3 2022 Oct 18, 2022	BUY	$4.58 - $9.21 $137,056 - $275,609	29,925 Added 36.46%	112,000 $771,000
Q2 2022 Aug 12, 2022	BUY	$7.06 - $23.63 $285,753 - $956,424	40,475 Added 97.3%	82,075 $686,000
Q1 2022 May 11, 2022	BUY	$21.6 - $27.79 $38,880 - $50,022	1,800 Added 4.52%	41,600 $950,000
Q4 2021 Feb 23, 2022	BUY	$23.0 - $29.01 $915,400 - $1.15 Million	39,800 New	39,800 $1.1 Million

264

256M

5.53M

16.6M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.3B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Mystic Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Mystic Asset Management, Inc. with notifications on news.